The Potential of Micropellets and Mini-Tablets in Oral Pediatric Formulations with Challenging APIs
To provide pediatric medicines also in developing countries at viable cost, a harmonization of pediatric product development and supply is suggested by WHO's GAP-f approach. Close cooperation between the different stakeholders supports a focused pediatric drug development and supply concept. A specialized pediatric CDMO (PedExpert CDMO) focusing on challenging APIs could mean an important step forward toward the goal 'Medicine for the children of the world.'
Authors
- Norbert Poellinger
Institutions
- West Pharmaceutical Services (United Kingdom) (GB)
Publication Details
- Journal
- Expert Opinion on Pharmacotherapy
- Published
- 2025-10-30
- DOI
- https://doi.org/10.1080/14656566.2025.2580359
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00